These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 16361579

  • 1. In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer.
    Brouwers AH, Boerman OC, Oyen WJ.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8886; author reply 8886. PubMed ID: 16361579
    [No Abstract] [Full Text] [Related]

  • 2. Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy.
    Signoretti S, Regan M, Atkins M.
    BJU Int; 2008 Jun 15; 101 Suppl 4():31-5. PubMed ID: 18430120
    [No Abstract] [Full Text] [Related]

  • 3. Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: experiences from (radio) immunotherapy.
    Brouwers AH, Mulders PF, Oyen WJ.
    J Clin Oncol; 2008 Aug 01; 26(22):3808-9; author reply 3811-2. PubMed ID: 18669472
    [No Abstract] [Full Text] [Related]

  • 4. Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma.
    Pantuck AJ, Klatte T, Seligson D, Atkins M, Belldegrun A.
    J Clin Oncol; 2008 Jun 20; 26(18):3105-7; author reply 3107-9. PubMed ID: 18565906
    [No Abstract] [Full Text] [Related]

  • 5. Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinoma.
    Jensen HK, Nordsmark M, Donskov F, Marcussen N, von der Maase H.
    BJU Int; 2008 Jun 20; 101 Suppl 4():41-4. PubMed ID: 18430123
    [No Abstract] [Full Text] [Related]

  • 6. Carbonic anhydrase IX expression in clear cell renal cell carcinomas negatively correlates with the proportion of the granular cell component.
    Skapa P, Hyrsl L, Zavada J, Soukup J, Zamecnik J.
    J Clin Oncol; 2008 Aug 01; 26(22):3809-11; author reply 3811-2. PubMed ID: 18669473
    [No Abstract] [Full Text] [Related]

  • 7. Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies.
    Shuch B, Li Z, Belldegrun AS.
    BJU Int; 2008 Jun 01; 101 Suppl 4():25-30. PubMed ID: 18430119
    [No Abstract] [Full Text] [Related]

  • 8. The pathway to biomarker discovery: carbonic anhydrase IX and the prediction of immune responsiveness.
    Panelli MC, Wang E, Marincola FM.
    Clin Cancer Res; 2005 May 15; 11(10):3601-3. PubMed ID: 15897553
    [No Abstract] [Full Text] [Related]

  • 9. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
    Tostain J, Li G, Gentil-Perret A, Gigante M.
    Eur J Cancer; 2010 Dec 15; 46(18):3141-8. PubMed ID: 20709527
    [Abstract] [Full Text] [Related]

  • 10. Carbonic anhydrase IX: historical and future perspectives.
    Oosterwijk E.
    BJU Int; 2008 Jun 15; 101 Suppl 4():2-7. PubMed ID: 18430115
    [No Abstract] [Full Text] [Related]

  • 11. Kidney cancer: Carbonic anhydrase IX in resected clear cell RCC.
    Pickering LM, Larkin J.
    Nat Rev Urol; 2015 Jun 15; 12(6):309-10. PubMed ID: 26032554
    [No Abstract] [Full Text] [Related]

  • 12. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
    Stillebroer AB, Mulders PF, Boerman OC, Oyen WJ, Oosterwijk E.
    Eur Urol; 2010 Jul 15; 58(1):75-83. PubMed ID: 20359812
    [Abstract] [Full Text] [Related]

  • 13. Carbonic anhydrase IX: role in diagnosis prognosis and cancer therapy. Introduction.
    Belldegrun AS, Bevan P.
    BJU Int; 2008 Jun 15; 101 Suppl 4():1. PubMed ID: 18430114
    [No Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase expression in kidney and renal cancer: implications for diagnosis and treatment.
    Oosterwijk E.
    Subcell Biochem; 2014 Jun 15; 75():181-98. PubMed ID: 24146380
    [Abstract] [Full Text] [Related]

  • 15. Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma.
    Leppert JT, Lam JS, Pantuck AJ, Figlin RA, Belldegrun AS.
    BJU Int; 2005 Aug 15; 96(3):281-5. PubMed ID: 16042714
    [Abstract] [Full Text] [Related]

  • 16. Carbonic anhydrase IX/G250/MN: a molecule too good to be true?
    Oosterwijk E.
    BJU Int; 2008 Mar 15; 101(5):527-8. PubMed ID: 18257853
    [No Abstract] [Full Text] [Related]

  • 17. Specific monoclonal antibody-based immunotherapy by targeting the RCC-associated antigen carbonic anhydrase-IX(G250/MN).
    Mulders P, Bleumer I, Debruyne F, Oosterwijk E.
    Urologe A; 2004 Sep 15; 43 Suppl 3():S146-7. PubMed ID: 15164181
    [No Abstract] [Full Text] [Related]

  • 18. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis.
    Giménez-Bachs JM, Salinas-Sánchez AS, Serrano-Oviedo L, Nam-Cha SH, Rubio-Del Campo A, Sánchez-Prieto R.
    Scand J Urol Nephrol; 2012 Oct 15; 46(5):358-64. PubMed ID: 22571179
    [Abstract] [Full Text] [Related]

  • 19. Expression and diagnostic implications of carbonic anhydrase IX in several tumours with predominantly clear cell morphology.
    Lin XY, Zhang H, Tang N, Zhang XP, Zhang W, Wang EH, Han YC.
    Histopathology; 2015 Apr 15; 66(5):685-94. PubMed ID: 25431204
    [Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase 9 expression increases with vascular endothelial growth factor-targeted therapy and is predictive of outcome in metastatic clear cell renal cancer.
    Stewart GD, O'Mahony FC, Laird A, Rashid S, Martin SA, Eory L, Lubbock AL, Nanda J, O'Donnell M, Mackay A, Mullen P, McNeill SA, Riddick AC, Aitchison M, Berney D, Bex A, Overton IM, Harrison DJ, Powles T.
    Eur Urol; 2014 Nov 15; 66(5):956-63. PubMed ID: 24821582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.